Sana Bio (SANA) Revenue & Revenue Breakdown
Sana Bio Revenue Highlights
00
Sana Bio Revenue by Period
Sana Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Sana Bio generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Sana Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $15.28M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $161.53M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | - |
Sana Bio generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Sana Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NKTR | Nektar Therapeutics | $98.43M | $11.79M |
| PHAT | Phathom Pharmaceuticals | $55.25M | $49.50M |
| NRIX | Nurix Therapeutics | $54.55M | $7.89M |
| SNDX | Syndax Pharmaceuticals | $23.68M | $45.87M |
| RLAY | Relay Therapeutics | $10.01M | - |
| DNTH | Dianthus Therapeutics | $6.24M | $193.00K |
| OCS | Oculis | $883.00K | - |
| INBX | Inhibrx Biosciences | $200.00K | - |
| KOD | Kodiak Sciences | - | - |
| SANA | Sana Bio | - | - |
| XNCR | Xencor | - | $43.61M |